Harriet M Kluger

32PUBLICATIONS
148CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyImmunogenetics (incl. genetic immunology)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|Jun 09, 2026
Advances in Cancer Immunotherapy for Solid Tumors.

|Feb 13, 2026
Ex Vivo Expansion of Melanoma Tumor-Infiltrating Lymphocytes Leads to a Dominant Exhausted T-cell Population with a Lack of Memory Markers.

Gianfilippo Coppola, Samuel Kerr, Pei-Chun Cha

|Dec 19, 2025
Phenotypic and functional characterization of tumor-reactive T cells in malignant pleural effusions.

Noam S Gaiger, Jack Coburn, Mark N Lee

|Sep 11, 2025
Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.

Lilach Aizenbud, Noam Savion Gaiger, Ana Luisa Perdigoto

|Jul 23, 2025
Humoral determinants of checkpoint immunotherapy.

Yile Dai, Lilach Aizenbud, Kai Qin

Pageof 6

Frequent Collaborators

7 joint publications

Ryan J Sullivan

6 joint publications

David Schoenfeld

5 joint publications

Mario Sznol

5 joint publications

Sarah A Weiss